Gold Moves Higher; Coca-Cola Increases FY24 Forecast
U.S. stocks traded slightly higher toward the end of trading, with the Dow Jones gaining by more than 50 points on Tuesday.
The Dow traded up 0.17% to 40,483.92 while the NASDAQ rose 0.20% to 18,043.64. The S&P 500 also rose, gaining, 0.14% to 5,572.07.
Check This Out: How To Earn $500 A Month From Alphabet Stock Ahead Of Q2 Earnings Report
Leading and Lagging Sectors
Consumer discretionary shares jumped by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 1.4%.
Top Headline
Coca-Cola Company (NYSE:KO) reported better-than-expected second-quarter results and raised its guidance.
The company reported second-quarter FY24 sales growth of 3% year-on-year to $12.4 billion, beating the analyst consensus estimate of $11.753 billion. Adjusted EPS of 84 cents beat the consensus estimate of 81 cents.
Coca-Cola raised its FY24 organic revenue growth outlook from 8% – 9% to 9% – 10%. KO raised comparable currency neutral EPS growth outlook from 11% – 13% to 13% – 15%.
Equities Trading UP
- Azitra, Inc. (NYSE:AZTR) shares shot up 326% to $6.91 after the company announced that the U.S. Patent and Trademark Office granted it U.S. Patent No. 12,036,248 for the treatment of atopic dermatitis.
- Shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) got a boost, surging 39% to $1.47 after the company announced it advanced into the second cohort and commenced dosing for the Pharmacokinetics Study of AD04 for alcohol use disorder.
- Frequency Electronics, Inc. (NASDAQ:FEIM) shares were also up, gaining 33% to $13.48 following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.
Equities Trading DOWN
- Jaguar Health, Inc. (NASDAQ:JAGX) shares dropped 57% to $1.84 after the company announced its phase 3 OnTarget trial results for Crofelemer did not meet its primary endpoint.
- Shares of TransCode Therapeutics, Inc. (NASDAQ:RNAZ) were down 62% to $0.30 after the company priced $3 million public offering of 10 million common shares at $0.30 per share.
- Cellectar Biosciences, Inc. (NASDAQ:CLRB) was down, falling 19% to $2.4502. The company announced results from its CLOVER WaM pivotal study evaluating iopofosine I 131.
Also Check This Out: Wall Street’s Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks With Over 3% Dividend Yields
Commodities
In commodity news, oil traded down 1.6% to $77.12 while gold traded up 0.5% at $2,407.20.
Silver traded down 0.1% to $29.305 on Tuesday, while copper fell 0.9% to $4.1605.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 climbed 0.13%, Germany's DAX gained 0.82% and France's CAC 40 fell 0.31%. Spain's IBEX 35 Index rose 0.62%, while London's FTSE 100 fell 0.38%.
Asia Pacific Markets
Asian markets closed lower on Tuesday, with Japan's Nikkei 225 falling 0.01%, Hong Kong's Hang Seng Index falling 0.94%, China's Shanghai Composite Index declining 1.65% and India's S&P BSE Sensex declining 0.09%.
The annual inflation rate in Hong Kong rose to 1.5% in June from 1.2% in the prior month. The People’s Bank of China slashed one-year loan prime rate by 10bps to 3.35%.
Economics
- The composite manufacturing index in the US Fifth District fell to -17 in July compared to a reading of -10 in June.
- Existing home sales declined by 5.4% from the prior month to an annualized rate of 3.89 million units for June.
Now Read This: This Coinbase Global Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday